Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria

Internet Journal of Tropical Medicine

Volumn 6, Issue 2, 2010, Pages

  Ugwuja, Emmanuel Ike ^a   Ugwu, Nicholas Chukwuka ^a  

^a EBONYI STATE UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; BILIRUBIN GLUCURONIDE; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; PROTEIN;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CIRCUMCISION; CONTROLLED STUDY; CULTURAL FACTOR; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NIGERIA; NORMAL HUMAN; PUBLIC HEALTH; SCAR FORMATION; SCHOOL CHILD; SEROPREVALENCE; SEX DIFFERENCE; SOCIAL STATUS; VIRUS TRANSMISSION;

EID: 77953415541     PISSN: None     EISSN: 15402681     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. WHO. Fighting disease, fostering development, World health Organisation Report, Geneva; 1996.
2. Moyer LA and Most EE. Hepatitis B virology epidemiology Disease and Prevention and an overview of viral Hepatitis, Immunisation in Medical Education. American family Physician 1995; 10 (S): 45-55.
3. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61:362-6.
4. Odusanya OO, Alufohai FE, Meurice FP, Wellens R, Weil J and Ahonkhai VI. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. International J Infect Dis 2005; 9(3): 139-143.
5. Alikor EA and Erhabor ON. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger delta of Nigeria. Niger J Med 2007; 16(3): 250-1.
6. S, Chetsanga C, Nystrom L, Moyo S, Nzara M and Chieza L. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe. S Afr Med J 1996; 86(1); 72-5.
7. Poel, Cuypers HT and Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1475-1479.
8. Bojuwoye BJ. The burden of viral hepatitis in Africa. West Afr J Med 1997; 16(4): 198-203.
9. Olumide EA. The distribution of HBsAg in Africa and the tropics: Report of a population study in Nigeria. International J Epidemiol 1996; 5(3): 279-289.
10. SK, Bolori MT, Ajayi NA, Aggada HA, Pindiga UH, Gashau W and Khalil MIA. Hepatocellular carcinoma in north-Eastern Nigeria: A prospective Clinical Study of 100 cases. The Internet Journal of Gastroenterology 2007; Volume 6 Number 1.
11. OO, Iseniyi JO, Kolawole MO and Ojuawo A. Risk factors and seroprevalence of hepatitis B surface antigenaemia in mothers and their pre-school age children in Ilorin, Nigeria. Therapy 2007; 4(1): 67-72.
12. Otegbayo JA, Fasola FA and Abja A. Prevalence of hepatitis B surface antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol 2003; 24(4); 196-7.
13. Nacos B, Dao B, Dahourou M et al. HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkinafaso). Dakar Med 2000; 42(2): 188-190.
14. CDC. A comprehensive immunisation strategy to eliminate transmission of hepatitis B virus infection in the united State: Recommendations of the Advisory Committee on Immunisation Practices (ACIP), Part I: Immunisation of infants, children and adolescents. MMWR 2005; 54(No.RR-16).
15. Reinhold JG. Total protein, albumin and globulin. In M Reiner (ed). Standard methods in clinical chemistry Vol. Academic Press, New York, 1953, Pp 88.
16. PG. The measurement of albumin in serum and plasma. Ann Clin Biochem 1985; 22: 565-578.
17. JO, Ezechukwu CC, Egbunonu I and Okoli CC. Prevalence of hepatitis B surface antigen in primary school children in Nnewi, Nigeria. Nig J Clin Pract 2004; 7(1): 8-10.
18. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS and Chen DS. Hepatitis B virus Infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis vaccination. Ann Int med 2001; 135(9): 796-800.
19. Al-Faleh FZ, Ayoola EA, Arif M, Ramia S, Al-Rashed R, Al-Jeffry M, Al-Mofarreh M, Al-Karawi M and Al-Shabrawy M. Seroepidemiology of hepatitis B virus infection in Saudi Arabian Children: a baseline survey for mass vaccination against hepatitis B. J Infect 1992; 24(2): 197-206.
20. Ezegbudo CN, Agbonlahor DE, Nwobu GO, Igwe CU, Agba MI, Okpala HO and Ikaraoha CI. The Seroprevalence of hepatitis B surface antigen and Human immunodeficiency virus among pregnant women in Anambra State, Nigeria. Shiraz E-medical Journal 2004; 5(2): 1-25.
21. AU, Sharaiha ZK, Abu-el-Rub OA, Hmoud MK, Dahbour SS, Hashem Abu-Hassan, Yacoub SM, Hadler SC, Margolis HS, Coleman PJ and Maynard JE. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol 1990; 132(2): 220-32.
22. Maddawa V, Burgess C and Drucker E. Epidemiology of chronic hepatitis C infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2:293-302.
23. HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ for The Taiwan Community-Based Cancer Screening Project Group. Hepatitis B antigen and the risk of hepatocellular carcinoma. N Eng J med 2002; 347: 168-74.
24. ATDN (a Simple Fact Sheet from the AIDS Treatment Data Network). Liver Function Tests available at: http://www.atdn.org/simple/liverfun.html (accessed 20/12/2008).